Atellica NEPH 630 System

Smart, simple, and secure protein testing

Atellica® NEPH 630 System* combines proven nephelometric testing with the industry’s broadest menu of plasma protein samples.

  • More than 70 assay protocols accommodate multiple sample types.
  • Continuous random-access processing provides flexible sample management, easy calibration, and reliable results.
  • Wide initial measuring range reduces the need for retesting.
  • Intelligent and secure software offers password-protected, predefined user-access profiles and integrated sample result traceability.
Siemens Healthineers nephelometric analyzer Atellica NEPH 630 System

Benefits

Atellica NEPH 630 System features the industry’s largest nephelometric menu of plasma protein assays.

Atellica NEPH 630 System features the industry’s largest nephelometric menu of plasma protein assays.

  • Flexible testing options enable testing on serum, urine, plasma, and CSF.
  • Broad assay menu of more than 70 assays supports therapeutic drug monitoring, cardiac risk assessment, kidney diseases, neurological disorders, nutritional assessment, and iron and anemia assessment.
Intelligent software supports safe operation and timely data transmission, safeguards patient data, and facilitates quick, convenient technical support, if needed.

Intelligent software supports safe operation and timely data transmission, safeguards patient data, and facilitates quick, convenient technical support, if needed.

  • Predefined user-access profiles are password-protected to support tiered operator permission levels for safe system operation and patient data privacy.
  • Smart Remote Services§ identifies and diagnoses potential hardware issues, enabling rapid technical intervention and quicker resolution.
  • Advanced QC interface provides comprehensive statistics, allowing the transmission of control results to the LIS.
Continuous random access and a fast average throughput of 65 tests‡ per hour support flexible sample processing and rapid results.

Continuous random access and a fast average throughput of 65 tests per hour support flexible sample processing and rapid results.

  • Flexible dilutions and automatic retesting can often be performed without re-accessing the primary sample.
  • Sophisticated sample dilutions enable you to quickly add tests or retest samples.
  • Samples and reagents can be loaded and reloaded continuously without interrupting the assay run.
  • Integrated sample result traceability functions support intuitive historical data search and provide access to 2 years of onboard data.
High-capacity storage and automated features reduce hands-on time.

High-capacity storage and automated features reduce hands-on time.

  • Onboard reagent and control storage provides 24/7 operation, long onboard stability, and minimized operator intervention.
  • High sample-loading capacity allows load-and-go processing.
  • Positive bar-code ID of primary sample tubes minimizes manual steps and avoids sample mismatch.
  • Automatic dilutions and repeat measurement of out-of-range high or low samples are performed without user intervention.
Proven nephelometric technology offers high precision and reproducibility that provide analytical advantages over turbidimetry in terms of precision and sensitivity.

Proven nephelometric technology offers high precision and reproducibility that provide analytical advantages over turbidimetry in terms of precision and sensitivity.1-4

  • High-sensitivity testing with nephelometry is considered the industry’s “gold standard” and is recommended by the IMWG and ESMO guidelines.5-7
  • Wide initial measuring ranges and sophisticated antigen-excess pre-reaction protocols provide more-accurate results and fewer repeats.
  • System detects specimen and reagent levels prior to processing to ensure accuracy of results.
  • Graphical display of kinetic curves allows additional insight and advanced troubleshooting.
Innovative assays coupled with trusted and proven technologies support clinicians with reliable insight into disease determination and progression.

Innovative assays coupled with trusted and proven technologies support clinicians with reliable insight into disease determination and progression.

  • N Latex FLC assay is the first immunoassay with clearance for evaluation of monoclonal gammopathies of undetermined significance (MGUS).**,††
  • PROTIS® clinical decision support software consolidates patient test results into one simple report with algorithm-based interpretation of results to support physicians in clinical decision making.
  • Lot-to-lot consistency ensures concordance of results, providing physicians with reliable insight into the progression of disease.
  • More than 50 years of experience in protein analysis has led to longtime cooperation with IFCC in developing widely accepted standards.
Atellica NEPH 630 System features the industry’s largest nephelometric menu of plasma protein assays.

Atellica NEPH 630 System features the industry’s largest nephelometric menu of plasma protein assays.

  • Flexible testing options enable testing on serum, urine, plasma, and CSF.
  • Broad assay menu of more than 70 assays supports therapeutic drug monitoring, cardiac risk assessment, kidney diseases, neurological disorders, nutritional assessment, and iron and anemia assessment.

Assay Menu

Download the assay menu

Polyclonal and Monoclonal Gammopathies/Immune System

10
ß2-Microglobulin
FLC kappa
FLC lambda
Ig/Light Chain type kappa
Ig/Light Chain type lambda
IgA
IgD*,‡‡
IgG
IgG subclasses 1-4
IgM

Autoimmune/Rheumatoid Diseases

8
ADNase B
ASL
Calprotectin*,‡‡
C3c
C4
CRP
RF
TNFa Inhibitors (adalimumab, infliximab, etanercept)*

Complement Activity

6
C1 Esterase Inhibitor
C1q*,‡‡
C3c
C3 Proactivator*,‡‡
C4
C5*,‡‡

Coagulation Disorders

3
AT-III
Fibrinogen
Plasminogen

Kidney Disease

12
α1-Microglobulin urine
α2-Macroglobulin urine*
ß2-Microglobulin urine
ß-trace protein*
Albumin urine
Cystatin C
FLC kappa urine*
FLC lambda urine*
Ig/Light Chain, type kappa urine*
Ig/Light Chain, type lambda urine*
IgG urine
Transferrin urine

Cardiovascular Risk/Acute Cardiac Care

9
Albumin urine
Apo A-I
Apo B
Cystatin C
Fibrinogen
High Sensitivity CRP (CardioPhase® hsCRP)
Homocysteine
Lp(a)
Myoglobin

Chronic Alcohol Abuse

2
CDT (Carbohydrate-deficient Transferrin)
Transferrin (for %CDT calculation)

Anemia/Iron Metabolism

5
Ferritin
Haptoglobin
Hemopexin
sTfR (Soluble Transferrin Receptor)
Transferrin

Blood-CSF Barrier Dysfunction

11
Albumin
Albumin CSF
ß-trace Protein (CSF leakage)*
FLC kappa CSF*
FLC lambda CSF*
IgA
IgA CSF
IgG
IgG CSF
IgM
IgM CSF

Inflammation

4
α1-Acid Glycoprotein
CRP
Fibrinogen
SAA*

Allergic Diseases

1
IgE

Other Specialty Analytes

6
α1-Antitrypsin
α2-Macroglobulin serum
Apo A-II*
Apo E*
Ceruloplasmin
Fibronectin

Nutritional Assessment

5
Albumin
CRP
Ferritin
Prealbumin
RBP (Retinol-binding Protein)

Τεχνικές Λεπτομέρειες

 

  • Nephelometric measurement principle measures scattered light intensity at a fixed angle of 13–24°.
  • More than 70 programmed assay protocols available.
  • Runs 65 tests/hour, depending on the assay mix.
  • Reaction cuvette capacity of 90 disposable cuvettes.
  • Flexible use of different sized sample tubes, including pediatric tubes.
  • Supports a variety of connectivity options, including Laboratory information systems (LIS), Smart Remote Services,§ Atellica Data Manager, and Atellica Process Manager.
Download Atellica NEPH 630 System Spec Sheet

Related Products

Plasma Protein Assays

Plasma Protein Assays

The broadest nephelometric assay menu available from a single source

BN II System

BN II System

Fully automated analyzer that offers an ideal fit for mid- to high-volume plasma-protein testing and provides confidence in results

Protis System

Protis IT Solution

Interpret multiple patient test results and provide doctors with a single assessment report

*
§
**
††
‡‡
1
2
3
4
5
6
7